The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...

Bad actors are using online ads, social media and bootleg ingredients to sell fake, inaccurate and harmful versions of these ...

Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

(The Hill) – Federal regulators shook up the booming weight ... drugs as Ozempic and Wegovy, all of them being GLP-1 agonists. Tirzepatide was first approved by the Food and Drug Administration ...

Millions of Americans rely on a new class of medications to manage chronic conditions like diabetes and obesity, with ...

that's considered "off-label" because that's outside of the FDA's approval. Your insurance company could deny Ozempic coverage if the prescription says it's being used for weight loss, not for ...

Tirzepatide was first approved by the Food and Drug Administration ... only options when it comes to weight loss or diabetes, and signficantly more affordable FDA-approved options do exist.